Αποτελέσματα Αναζήτησης
Individuals with ASD frequently are treated with multiple medications, including off-label use (e.g., use of antipsychotic medications in younger children). Studies have reported high rates of polypharmacy ranging from 12 to 35% based on the type of studies [28, 29].
1 Οκτ 2020 · A single study investigated the potential utility of stimulant medication for treatment of depression symptoms in children and adolescents with ASD (Golubchik, Rapaport, & Weizman, 2017). Twelve youth ranging in age from 8-18 years (M = 11) participated in the medication trial. Ten participants were male.
A small study of 33 adolescents with Asperger syndrome (aged 12 to 17 years) showed 9% scoring in the significant range for depression on the Children’s Depression Inventory (CDI); however, 70% of the study participants were already being treated with antidepressants [21,22].
29 Νοε 2019 · Citicoline has been recently used with benefit in treatment of childhood neuro-psychiatric disorders including mental retardation , pervasive developmental disorders including Rett syndrome ,...
30 Αυγ 2021 · Aripiprazole has been approved by the FDA to treat irritability associated with autistic disorder in children and adolescents 5–16 years of age.
A systematic review by Jobski et al 5 included 47 studies of the prevalence of psychotropic medication use in people with ASD (N > 300 000) published between 1976 and 2012. The overall median rate of psychotropic use was 45.7%, which was higher among adults (61.5%) than children (41.9%).
1 Ιαν 2019 · Cerebrolysin is the only medical therapy that is known to be associated with significant improvement and even cure of the major autistic features (Poor response to name and poor eye contact which...
